Philippe Lefebvre
Lille, 59000, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 95 publications
The circadian clock controls hepatic stellate cell activation via a BMAL1/CK1ε/REV-ERBα/transgelin signaling pathway.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: July 21, 2026
Human liver perfluorooctane sulfonate associates with steatotic liver disease in a sex-dependent manner.
Journal: Environment international
Published: June 26, 2025
Anti-inflammatory, but not lipid-lowering, activity of hepatocyte PPARα improves atherosclerosis in Ldlr-deficient mice.
Journal: Science translational medicine
Published: May 28, 2025
Intrahepatic levels of microbiome-derived hippurate associates with improved metabolic dysfunction-associated steatotic liver disease.
Journal: Molecular metabolism
Published: August 21, 2024
Corrigendum to "Adipocyte-specific FXR-deficiency protects adipose tissue from oxidative stress and insulin resistance and improves glucose homeostasis" [Mol Metab 69 (2023) 1-13].
Journal: Molecular metabolism
Published: May 27, 2024
Nuclear receptors: pathophysiological mechanisms and drug targets in liver disease.
Journal: Gut
Published: March 28, 2024
Decreased circulating IPA levels identify subjects with metabolic comorbidities: A multi-omics study.
Journal: Pharmacological research
Published: March 13, 2024
O-GlcNAcylation controls pro-fibrotic transcriptional regulatory signaling in myofibroblasts.
Journal: Cell death & disease
Published: January 25, 2024
Unveiling the molecular legacy of transient insulin resistance: Implications for hepatic metabolic adaptability.
Journal: Journal of hepatology
Published: December 26, 2023
Last Updated: 09/26/2026